METABOLISM OF NUCLEOSIDES AND NUCLEOTIDES - IMPLICATIONS FOR THE DESIGN OF NEW ANTI-HIV DRUGS

Authors
Citation
B. Roy et M. Fontecave, METABOLISM OF NUCLEOSIDES AND NUCLEOTIDES - IMPLICATIONS FOR THE DESIGN OF NEW ANTI-HIV DRUGS, Bulletin de l'Institut Pasteur, 91(2), 1993, pp. 89-100
Citations number
36
Categorie Soggetti
Virology,Microbiology,Immunology
ISSN journal
00202452
Volume
91
Issue
2
Year of publication
1993
Pages
89 - 100
Database
ISI
SICI code
0020-2452(1993)91:2<89:MONAN->2.0.ZU;2-V
Abstract
Nucleoside analogs belong to an important class of anti-HIV drugs. The ir therapeutic and toxic effects are controlled by a variety of enzyma tic systems which use nucleosides and nucleotides as substrates, inhib itors or allosteric effectors. In order to better understand this cont rol, it is necessary to increase our knowledge of the general metaboli sm of nucleosides and nucleotides. This review describes the various e nzymes, such as ribonucleotide reductase, dCMP deaminase, kinases and nucleotidases, which participate in this metabolism.